Mannkind (MNKD) EBIT Margin (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 502.00 |
| Dec 31, 2025 | -2,987.00 |
| Sep 30, 2025 | 1,608.00 |
| Jun 30, 2025 | -2,153.00 |
| Mar 31, 2025 | -606.00 |
| Dec 31, 2024 | 1,630.00 |
| Sep 30, 2024 | -474.00 |
| Jun 30, 2024 | -229.00 |
| Mar 31, 2024 | 1,180.00 |
| Dec 31, 2023 | 349.00 |
| Sep 30, 2023 | 640.00 |
| Jun 30, 2023 | 1,830.00 |
| Mar 31, 2023 | 2,071.00 |
| Dec 31, 2022 | -619.00 |
| Sep 30, 2022 | 678,872.00 |
| Jun 30, 2022 | -664,075.00 |
| Mar 31, 2022 | 1,426.00 |
| Dec 31, 2021 | -16,184.00 |
| Sep 30, 2021 | 1,446.00 |
| Jun 30, 2021 | -862.00 |
| Mar 31, 2021 | 9,325.00 |
| Dec 31, 2020 | -6,929.00 |
| Sep 30, 2020 | 389,803.00 |
| Jun 30, 2020 | -391,364.00 |
| Mar 31, 2020 | 2,712.00 |
| Dec 31, 2019 | 118,316.00 |
| Sep 30, 2019 | 422,186.00 |
| Jun 30, 2019 | -539,855.00 |
| Mar 31, 2019 | -2,923.00 |
| Dec 31, 2018 | 43,384.00 |
| Sep 30, 2018 | 4,548.00 |
| Jun 30, 2018 | 24,559.00 |
| Mar 31, 2018 | -13,655.00 |
| Dec 31, 2017 | 74,272.00 |
| Sep 30, 2017 | 8,030.00 |
| Jun 30, 2017 | -80,815.00 |
| Mar 31, 2017 | -55,605.00 |
| Dec 31, 2016 | -16,822.00 |